CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
71.58
1.33%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon: 14:30 - 21:00

Tue: 14:30 - 18:00

Thu - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.17
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 70.64
Open 71
1-Year Change -0.18%
Day's Range 70.89 - 71.78
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 71.58 1.42 2.02% 70.16 71.80 70.16
Dec 19, 2024 70.64 -0.48 -0.67% 71.12 71.92 70.52
Dec 18, 2024 71.15 -0.61 -0.85% 71.76 72.59 71.14
Dec 17, 2024 72.01 0.04 0.06% 71.97 73.87 71.72
Dec 16, 2024 72.14 -0.64 -0.88% 72.78 73.85 72.10
Dec 13, 2024 73.58 -0.88 -1.18% 74.46 74.83 73.35
Dec 12, 2024 75.04 -0.49 -0.65% 75.53 76.12 74.77
Dec 11, 2024 75.24 -0.61 -0.80% 75.85 76.97 74.65
Dec 10, 2024 76.79 1.54 2.05% 75.25 80.07 74.76
Dec 9, 2024 75.74 0.36 0.48% 75.38 76.17 74.17
Dec 6, 2024 75.17 -0.08 -0.11% 75.25 76.24 74.79
Dec 5, 2024 75.94 -0.56 -0.73% 76.50 76.72 75.46
Dec 4, 2024 76.77 -0.64 -0.83% 77.41 77.65 76.20
Dec 3, 2024 77.36 -0.53 -0.68% 77.89 78.63 77.16
Dec 2, 2024 78.93 0.28 0.36% 78.65 79.17 77.77
Nov 29, 2024 79.37 0.14 0.18% 79.23 79.64 78.77
Nov 27, 2024 79.19 0.59 0.75% 78.60 79.59 78.56
Nov 26, 2024 78.74 -0.46 -0.58% 79.20 79.85 78.52
Nov 25, 2024 79.47 0.69 0.88% 78.78 80.01 78.65
Nov 22, 2024 78.81 0.18 0.23% 78.63 79.24 78.39

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Hologic Company profile

About Hologic, Inc.

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.

Financial summary

BRIEF: For the three months ended 25 December 2021, Hologic, Inc. revenues decreased 9% to $1.47B. Net income decreased 24% to $499.2M. Revenues reflect Diagnostics segment decrease of 16% to $950.4M, United States segment decrease of 11% to $1.01B, Europe segment decrease of 13% to $295.1M, All Others. segment decrease of 4% to $43.9M. Net income also reflects Diagnostics segment income decrease of 32% to $531.8M.

Equity composition

Common Stock $.01 Par, 03/11, 750M auth., 261,612,000 issd., less 219,000 shs. in Treas. @ $1.5M. Insiders & Strategic holders own 0.49%. . PO 6/90, 805K shares @ $23 by Hambrecht & Quist. 12/07, Co. acquired Cytyc Corporation @ 0.52 shares (60,622,143 shares issd.). 04/08, 2-for-1 stock split.

Industry: Advanced Medical Equipment & Technology (NEC)

250 Campus Drive
MARLBOROUGH
MASSACHUSETTS 1752
US

People also watch

ETH/USD

3,326.39 Price
+0.300% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

2.25 Price
+0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01120

Gold

2,623.59 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading